99mTc-M-TRODAT is not superior to 99mTc-TRODAT-1 for the diagnosis of Parkinson's disease [2]

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 5, 2003, Pages 796-797

  Verbruggen, A ^a   Maes, A ^a   Vanbilloen, H ^a   Cleynhens, B ^a   Mortelmans, L ^a   Bormans, G ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROPROPYL BETA CIT I 123; IOFLUPANE; RADIOPHARMACEUTICAL AGENT; TRODAT M TC 99M; UNCLASSIFIED DRUG; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; CARRIER PROTEIN; DIAGNOSTIC AGENT; DOPAMINE TRANSPORTER; MEMBRANE PROTEIN; NERVE PROTEIN; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TRODAT 1; TECHNETIUM TC 99M TRODAT-1; TROPANE DERIVATIVE;

BASAL GANGLION; CASE REPORT; CEREBELLUM; CONTROLLED STUDY; DRUG PURIFICATION; DRUG SYNTHESIS; DRUG UPTAKE; ELECTROENCEPHALOGRAM; HUMAN; IMAGE QUALITY; ISOTOPE LABELING; LETTER; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PARKINSON DISEASE; PILOT STUDY; PROSPECTIVE STUDY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCINTISCANNING; TREATMENT OUTCOME; BRAIN; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; METABOLISM; NOTE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BASAL GANGLIA; BRAIN; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; ORGANOTECHNETIUM COMPOUNDS; PARKINSON DISEASE; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TROPANES;

EID: 0037907523     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1125-1     Document Type: Letter

References (8)

1. 123I-FP-beta-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur J Nucl Med 1997; 24:68-71.
2. Walker Z, Costa DC, Ince P, Mc Keith IG, Katona CL. In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet 1999; 354:646-647.
3. Kung HF, Kim HJ, Kung MP, Meegalla SK, Plössl K, Lee H-K. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med 1996; 23:1527-1530.
4. Mozley LH, Gur RC, Mozley PD, Gur RE. Striatal dopamine transporters and cognitive functioning in healthy men and women. Am J Psychiatry 2001; 158:1492-1499.
5. 99mTc TRODAT-1: a dopamine transporter imaging agent. J Nucl Med 1999; 40:150-158.
6. Plössl K, Kung M-P, Meegalla SK, Dresel S, Kushner SA, Mu M, Huang X-F, Mozley PD, Kung HF. [Tc-99m]M-TRODAT: an improved dopamine transporter imaging agent. J Nucl Med 1998; 39:6P.
7. Meegalla SK, Plössl K, Kung M-P, Chumpradit S, Stevenson DA, Kushner SA, McElgin WT, Mozley PD, Kung HF. Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents. J Med Chem 1997; 40:9-17.
8. 99mTc-TRODAT-1. J Labelled Compd Radiopharm 2001; 44:S529-S531.